Make eligibility an individual clinical discussion
NIDDK explains that weight-management medicines are selected with a health professional using the potential benefits, possible side effects, current health, other medicines and family history. A women’s or men’s comparison is a way to organize that discussion, not a separate prescribing standard. Weight-loss medication should not be used during pregnancy or when planning pregnancy. Ask the clinician about the exact product’s reproductive and breastfeeding guidance and any medicine-related questions; do not infer a schedule from another preparation.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
1. CoreAge Rx: medicine, care and ordinary cost
CoreAge publishes compounded semaglutide at $79 per month on a 12-month plan and says there is no membership fee. That gives a straightforward reference beside services with separate care charges. The useful budget question is what supply and follow-up the selected prescription includes, and whether the quoted rate remains the same at renewal. Its $129/month on a 12-month plan tirzepatide offer belongs in a different medicine comparison. Read CoreAge Rx review and the actual semaglutide product page before treating the displayed monthly figure as a personalized prescription quote.
Ask how the clinician reviews current medicines and reproductive plans before choosing the prescription. A direct compound offer should identify the actual preparation and pharmacy; a women-focused page cannot establish eligibility. Read the CoreAge Rx review for the full care and purchase model.
CoreAge Rx’s updated starting prices are $79/month equivalent for semaglutide and $129/month for tirzepatide on 12-month plans ($948 and $1,548 total). One-month plans cost $139 and $199. No separate membership fee is advertised. These figures describe selected supply periods, not every product or a completed order; confirm the exact prescription and invoice.
For a women-focused shortlist, CoreAge Rx still needs a specific role in the individual routine. Its purchase reference is Semaglutide from $79/month; tirzepatide from $129/month, both on 12-month plans. The full formulation and relevant health or reproductive questions belong with the appropriate professional where needed. Compare the ordinary selected order and the support route, without treating a demographic category as evidence of a distinct hormonal or treatment effect.
Sources: Semaglutide - CoreAge Rx · Tirzepatide - CoreAge Rx · CoreAge Rx - Your Health On Your Time · CoreAge Rx — Refund, Return, Subscription & Shipping Policy - CoreAge Rx · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · Prescription Medications to Treat Overweight & Obesity - NIDDK
2. SuperHealthy Rx — GLP-1 care
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. [Current offer](https://try.superhealthyrx.com/superhealthy-v1?utm_source=top5glp1.com&utm_medium=referral&utm_campaign=provider_comparison).
Sources:
3. Likeness Rx — GLP-1 weight care
A clear buying decision starts with the selected supply period. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
Sources: Likeness Rx — GLP-1 weight care
4. Ro: medicine, care and ordinary cost
Ro lists an ongoing $149 month-to-month membership after a $39 first month, with medication extra. Its $74 monthly equivalent is attached to a twelve-month prepaid membership; intermediate prepaid terms have different equivalents. Those longer terms may lower the displayed average while requiring a larger upfront care payment. Ro review helps compare the membership and medicine separately. A person choosing monthly flexibility should calculate with the actual $149 membership and selected medication bill, then ask which enrollment and pharmacy charges can be refunded.
Clarify which clinician answers a pregnancy-planning or changed-health question. Administrative support, insurance help and coaching are separate from a product-specific prescribing assessment. Read the Ro review for the full care and purchase model.
This review was written from official public pages available on October 1, 2026. We did not receive patient care, test medication, inspect a pharmacy or verify a completed purchase. Prices and program descriptions can change. FDA’s warning about unapproved GLP-1 products explains a regulatory distinction; it is not independent validation of this particular provider or product. Individual benefits, risks and eligibility require a qualified clinician.
Compare Ro by the actual preparation and the reason a woman is considering it. The published reference is Membership $39 first month, then $149/month monthly or $74/month equivalent on annual prepayment; medicine extra. Age, menopause and reproductive plans can raise different questions depending on the product, rather than establish one shared requirement. Keep those questions beside the current routine and complete label before interpreting the purchase terms or adding another product.
Sources: Weight Loss Program Pricing | Ro · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · Prescription Medications to Treat Overweight & Obesity - NIDDK
5. Mochi Health: medicine, care and ordinary cost
Mochi shows compounded semaglutide medication cards from $60, alongside a separate $79 monthly membership. A new-member membership promotion is $39 for the first month, with medication and diagnostic services excluded from that membership charge. Combining the displayed standard membership and minimum medication card produces an illustrative $139 before any separate diagnostics, if that medication figure applies to the selected order. It is not a universal quote or a price promise. Mochi Health review explains why the smallest medication card should not be compared directly with a prescription-inclusive plan.
Ask which nutrition or clinical contacts are included and how a relevant concern is referred. A program feature should not be treated as a guarantee of women-specific outcomes or specialist care. Read the Mochi Health review for the full care and purchase model.
The current page shows compounded semaglutide from $60, tirzepatide from $90 and a semaglutide pill from $62, alongside other oral choices. These are medication-card starting figures. The opening material reviewed does not establish a complete, universal membership-plus-medicine total. Comparing one of those figures with another company’s bundled program price would mix different units of purchase.
The useful record for Mochi Health combines its complete ingredients, intended role and purchase reference, Membership $39 introductory month where available, then $79/month; medication cards from $60 semaglutide/$90 tirzepatide extra. A women-focused page makes those fields easier to find but cannot establish individual suitability. Ask what changes in the existing routine and whether another product already occupies that role. The full review supplies the detailed formulation and order context.
Sources: Telehealth for Weight Loss, Hair Loss, Skin & More | Mochi Health · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · Prescription Medications to Treat Overweight & Obesity - NIDDK
6. Noom Med: medicine, care and ordinary cost
Noom’s price page shows a GLP-1Rx program at $129 to start and $249 per month after the first four-week supply, billed quarterly. It separately lists branded-medication telehealth at $39 to start and $129 monthly after month one, also billed quarterly, with medication excluded. That second care-only figure is not an alternative $129 complete prescription plan. Read Noom Med review for the program distinctions. Someone paying cash needs the named plan and medication inclusion in writing before comparing Noom with a medicine-inclusive service.
Identify the exact named plan and its medication terms. Separate any care membership from the prescription bill, and ask how a clinically necessary change affects the order agreement. Read the Noom Med review for the full care and purchase model.
The GLP-1Rx program lists $129 to start and $249 per month after the initial four-week supply, billed quarterly. Plus lists $149 to start and $299 per month afterward, also quarterly. Microdose lists $49 to start and $179 per month afterward. Those figures should not be reduced to a single Noom price; the later bill and program selection matter more than the cheapest opening headline.
For a women-focused shortlist, Noom Med still needs a specific role in the individual routine. Its purchase reference is GLP-1Rx $129 start, then $249/month billed quarterly. The full formulation and relevant health or reproductive questions belong with the appropriate professional where needed. Compare the ordinary selected order and the support route, without treating a demographic category as evidence of a distinct hormonal or treatment effect.
Sources: Noom Med - GLP-1 Medications for Weight Loss · Noom Med Plans & Pricing | GLP-1 & Weight Loss Programs · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · Prescription Medications to Treat Overweight & Obesity - NIDDK
7. RemedyMeds: medicine, care and ordinary cost
RemedyMeds advertises compounded semaglutide and tirzepatide through an online care pathway. Its page emphasizes month-to-month participation and also promotes a microdose program. The precise selected preparation matters more than the broad GLP-1 label on the homepage.
Request the actual product, ordinary invoice and continuing clinical contact. Read any outcome or refund-guarantee claims with their conditions rather than treat them as a personal promise. Read the RemedyMeds review for the full care and purchase model.
This review was written from official public pages available on October 1, 2026. We did not receive patient care, test medication, inspect a pharmacy or verify a completed purchase. Prices and program descriptions can change. FDA’s warning about unapproved GLP-1 products explains a regulatory distinction; it is not independent validation of this particular provider or product. Individual benefits, risks and eligibility require a qualified clinician.
Compare RemedyMeds by the actual preparation and the reason a woman is considering it. The published reference is Exact recurring price not established in the reviewed opening. Age, menopause and reproductive plans can raise different questions depending on the product, rather than establish one shared requirement. Keep those questions beside the current routine and complete label before interpreting the purchase terms or adding another product.
Sources: RemedyMeds · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · Prescription Medications to Treat Overweight & Obesity - NIDDK
Compare the care model after identifying the actual medicine
A GLP-1 program can combine medical assessment, a prescription, pharmacy fulfillment, coaching and administrative support. Different providers bundle these differently. Start by identifying what is included in the care payment and which medicine cost is separate. NIDDK describes prescription weight-management medicines as part of care that considers benefits, side effects, health history and other medicines. A branded-access program and a direct compounded offer should remain distinct in that conversation.
Semaglutide and tirzepatide are ingredient names, rather than a complete description of every product sold under them. Manufacturer-branded medicines have their own approved labels; compounded preparations are not FDA-approved finished products. The pharmacy, preparation and final instructions therefore belong beside the price. FDA has described concerns with unapproved GLP-1 products, including dosing and sourcing issues. A useful comparison identifies the exact order and continuing clinical contact before treating a broad category name as enough information.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
What an audience-focused shortlist can clarify for women
A women-focused comparison is most useful when it organizes relevant individual questions rather than invent a separate result standard. Bring the actual routine, current prescriptions and the reason for the purchase into view. Pregnancy, pregnancy planning, breastfeeding or menopause-related concerns can be relevant depending on the product, but they are different circumstances and should not be collapsed into one marketing category. Ask about the actual preparation and intended role with the appropriate professional.
The buying comparison then returns to ordinary details: complete ingredients, a readable full serving or prescription label, actual quantity and the continuing invoice. A women’s product can be convenient without demonstrating a hormonal benefit or a special response for everyone. Where another product already fills the same role, compare what changes rather than add both automatically. The aim is a shortlist that supports a specific conversation and a transparent order, with clinical suitability handled separately from the category used to find the page.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Clinical eligibility and the payment decision are separate steps
NIDDK describes weight-management prescribing as an individual decision that considers potential benefits, possible side effects, current health, other medicines and family history. For adults, its general discussion includes BMI of 30 or greater, or 27 or greater with weight-related health problems. Those are starting clinical considerations rather than an eligibility test supplied by this page. The clinician assesses the actual product and circumstances; a sales offer or membership payment cannot establish the prescription.
Discuss reproductive plans and other relevant changes before enrollment and during care. NIDDK advises against weight-loss medication during pregnancy or when planning pregnancy. Confirm the selected product’s own information with the clinician rather than transfer advice from another preparation. Once the care decision is made, obtain the complete medicine and service invoice, the ordinary renewal and the process for a clinically necessary change. That keeps treatment assessment and financial commitment understandable without making either one substitute for the other.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Is a care membership the same thing as a medication-inclusive plan?
No. A membership can cover assessment, visits, coaching or insurance assistance while a pharmacy charges separately for medication. A direct offer may bundle some of those costs. Ask for the selected plan’s complete invoice and exact product, including delivery and ordinary renewal. Compare what each payment actually buys rather than place an introductory service fee in the medicine column.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Are branded medicines and compounds the same finished products?
They should remain distinct. Manufacturer-branded medicines have their own approved labels, while compounded preparations are not FDA-approved finished products. The pharmacy, concentration, ingredients and directions must be identified for the actual prescription. Trials of a branded product do not establish the results of an unspecified compound. A program comparison should make those identities clear rather than assume equivalence from an ingredient name.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
What should happen if the prescription changes after assessment?
Ask the provider how the change affects medication supply, care fees and any advance payment. Those terms belong in the selected agreement and may differ between a membership and a prescription-inclusive purchase. Keep the prescribing contact available for clinical questions and customer support available for the order. A paid renewal or shipment notice is not, by itself, confirmation that the same treatment remains appropriate.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Compare the actual prescription and ongoing invoice
Request the complete first payment, medicine cost and ordinary renewal. A monthly equivalent, membership charge and prescription-inclusive offer purchase different things. Confirm how a clinical change affects payment or supply, and keep the prescriber’s contact route separate from routine customer support. Read the complete cost comparison and the commitment comparison before enrolling.
Before enrollment, ask for a written explanation of the selected care plan and the payment schedule. Record the medicine, included clinical contact, any separate pharmacy bill and the ordinary renewal amount. If the prescription is not issued or changes after assessment, find out how that affects fees and supply. Save those terms beside the clinician’s contact details. This creates a practical basis for comparing programs without assuming that an intake questionnaire, coaching package or sales call guarantees the treatment the reader expected.
For the audience-focused care questions, read Best GLP-1 programs for men: five care and cost comparisons.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Official sources
Public-page information checked October 1, 2026. Prices, availability and terms can change. We did not perform patient care or checkout.
- Semaglutide - CoreAge Rx ↗Checked 2026-10-01 · official public source
- Tirzepatide - CoreAge Rx ↗Checked 2026-10-01 · official public source
- Weight Loss Program Pricing | Ro ↗Checked 2026-10-01 · official public source
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss ↗Checked 2026-10-01 · official public source
- Telehealth for Weight Loss, Hair Loss, Skin & More | Mochi Health ↗Checked 2026-10-01 · official public source
- Noom Med - GLP-1 Medications for Weight Loss ↗Checked 2026-10-01 · official public source
- Noom Med Plans & Pricing | GLP-1 & Weight Loss Programs ↗Checked 2026-10-01 · official public source
- RemedyMeds ↗Checked 2026-10-01 · official public source
- Prescription Medications to Treat Overweight & Obesity - NIDDK ↗Checked 2026-10-01 · official public source
- CoreAge Rx - Your Health On Your Time ↗Checked 2026-10-01 · official public source
- CoreAge Rx — Refund, Return, Subscription & Shipping Policy - CoreAge Rx ↗Checked 2026-10-01 · official public source